THE RISK OF SERIOUS INFECTIONS BEFORE AND AFTER ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE – A RETROSPECTIVE COHORT STUDY

Johanna Holmgren  ¹     Anna Fröborg  ²     Isabella Visuri  ³     Jonas Halfvarson  ⁴     Henrik Hjortswang  ⁵     Pontus Karling  ⁶     Pär Myrelid  ⁶     Ola Olén  ⁷     Jonas F Ludvigsson  ⁷     Olof Grip  ^8    
1 Lund University / Section of Medicine, Malmö, Sweden
² Lund University, Karlskrona, Sweden
³ Faculty of Medicine and Health, Örebro University, Örebro, Sweden
⁴ Örebro University, Örebro, Sweden
⁵ Linköping University Hospital, Linköping, Sweden
⁶ Umeå University, Umeå, Sweden
⁷ Karolinska Institutet, Stockholm, Sweden
⁸ Skane University Hospital, Malmö, Sweden

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)